Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
Open Access
- 1 June 2021
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 80 (6), e94
- https://doi.org/10.1136/annrheumdis-2020-218244
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New YorkNew England Journal of Medicine, 2020
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registryAnnals Of The Rheumatic Diseases, 2020
- COVID-19 and systemic lupus erythematosus: a case seriesThe Lancet Rheumatology, 2020
- COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicineAnnals Of The Rheumatic Diseases, 2020
- Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquineAnnals Of The Rheumatic Diseases, 2020
- Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)Clinical Infectious Diseases, 2020
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesAnnals Of The Rheumatic Diseases, 2019